Target intelligence / Profile preview

Signal peptide peptidase-like 3 (SPPL3)

Target
SPPL3
Molecular classification
Enzyme, Aspartic protease, Intramembrane-cleaving protease
01

Overview

Signal peptide peptidase-like 3 (SPPL3) is a member of the signal peptide peptidase family of intramembrane-cleaving aspartic proteases, related to presenilins[3][4]. SPPL3 is predominantly located in the Golgi apparatus and acts as a sheddase, releasing the active site-containing ectodomains of glycan-modifying glycosidases, thereby regulating glycosylation and protein secretion[6]. Unlike some family members, SPPL3 is not primarily involved in immune surveillance or peptide antigen processing but rather in the modulation of glycosylation patterns, which has implications for cell signaling, tumor biology, and immunomodulation[6][3][4][5]. As of current literature, SPPL3 is not a direct drug target, nor are there established drugs or biomarkers based on its activity, but it is a relevant emerging target for research at the intersection of enzymology, glycomics, and disease biology.

Other names
SPPL3Signal peptide peptidase like 3Q8TCT6 (UniProt Accession)
02

Mechanism of action

no drugs targeting SPPL3; general mechanism is intramembrane aspartyl protease activity

03

Biological functions

Intramembrane proteolysisGlycan modificationRegulation of glycosylation enzymesModulation of protein secretion
04

Disease associations

CancerImmune modulationPotential involvement in other diseases related to glycosylation defects
05

Safety considerations

Potential broad effects on glycosylation pathways in normal and disease tissues; disruptions may impact immune function and cellular signaling

Beyond the preview

Go deeper on Signal peptide peptidase-like 3 (SPPL3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Signal peptide peptidase-like 3 (SPPL3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call